Diseases
Epilepsy is a widespread neurological condition that significantly affects the quality of life of those affected, with increasing rates of incidence and prevalence. A recent study published in the BMC Neurology journal has evaluated the global, regional, and national burdens of idiopathic epilepsy (IE) in individuals aged 15 to 49
Chronic obstructive lung disease
A recent meta-analysis of 12 studies published in Frontiers in Medicine has found that combining long-term oxygen therapy (LTOT) with exercise rehabilitation can significantly improve exercise capacity, cardiopulmonary function, and quality of life in patients with chronic obstructive pulmonary disease (COPD). The study, conducted by researchers at the Affiliated Hospital
Alzheimer's disease
A new case study published in Alternative Therapies In Health and Medicine has found that Ayurvedic interventions can aid in slowing cognitive decline and improving daily functioning in patients with Alzheimer's disease. The study, led by Sourabh Deshmukh, presents a clinical case study of a 55-year-old male patient
Diseases
In a recent study, researchers at Juntendo University have identified two cases of re-emergent tremors involving the tongue in patients with Parkinson's disease (PD). This report highlights the recognition of re-emergent tremors in the facial regions as potential manifestations of PD, emphasizing the need for more comprehensive and
Adults
A recent study published in the journal Frontiers in Human Neuroscience has provided new insights into the cortical responses to sensorimotor perturbations in individuals with Parkinson's disease. The research, conducted by investigators from the Edmond and Lily Safra International Institute of Neuroscience, utilized a novel Perturbatory Electrical Stimulation
Diseases
INVE Aquaculture and Dalan Animal Health have joined forces to tackle one of the shrimp industry's greatest challenges: disease management. The collaboration aims to accelerate the development of innovative solutions for shrimp disease prevention, addressing a critical obstacle to sustainable shrimp production worldwide. Dalan Animal Health is developing
Diseases
Researchers at the Azienda Sanitaria Universitaria Friuli Centrale in Italy have made a groundbreaking discovery in the field of Parkinson's disease research. A 45-year-old patient with a rare case of early-onset Parkinson's disease, associated with intellectual disability, was found to have a previously unknown pathogenic sequence
Diseases
Researchers from the Fourth People's Hospital of Shenyang in the People's Republic of China have conducted a comprehensive study on the association between brain-derived neurotrophic factor (BDNF) levels and Parkinson's disease. The study, involving 48 articles and a total of 2,589 patients with
Diseases
Monte Rosa Therapeutics, a clinical-stage biotechnology company, recently announced the presentation of preclinical data on MRT-6160, a rationally designed molecular glue degrader (MGD), at the ACR Convergence 2025 conference. The data demonstrate the potential of MRT-6160 to address multiple autoimmune and inflammatory diseases, including systemic lupus erythematosus, Sjogren's
Antiparkinson agents
A new study published in the Journal of Neural Transmission has found that the routine use of levodopa-entacapone-carbidopa intrajejunal infusion (LECIG) significantly reduces the burden of non-motor symptoms (NMS) in advanced Parkinson's disease patients. The study, known as the ELEGANCE study (NCT05043103), collected real-world data on long-term efficacy,
Diseases
A recent study by the PD-AGE consortium addresses the need for standardized methods in in vitro modeling to study Parkinson's disease. The research, led by experts from the University of Sheffield, highlights the importance of human induced pluripotent stem cell (iPSC)-derived models and chemically induced aging methods
Cholesterol
Researchers from the Alborz University of Medical Sciences in Karaj, Iran, have conducted a systematic review and meta-analysis of 34 studies to evaluate the association between novel atherogenic indices and the pathophysiology of metabolic dysfunction-associated steatotic liver disease (MASLD). The study found that non-high-density lipoprotein cholesterol (non-HDL-C) and non-HDL-C/HDL-C
